These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11791088)

  • 21. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum leptin levels and body composition in postmenopausal women: effects of hormone therapy.
    Di Carlo C; Tommaselli GA; Sammartino A; Bifulco G; Nasti A; Nappi C
    Menopause; 2004; 11(4):466-73. PubMed ID: 15243285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum leptin is increased in growth hormone-deficient adults: relationship to body composition and effects of placebo-controlled growth hormone therapy for 1 year.
    Fisker S; Vahl N; Hansen TB; Jørgensen JO; Hagen C; Orskov H; Christiansen JS
    Metabolism; 1997 Jul; 46(7):812-7. PubMed ID: 9225837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of hormone therapy on the enteroinsular axis.
    Sztefko K; Rogatko I; Milewicz T; Józef K; Tomasik PJ; Szafran Z
    Menopause; 2005; 12(5):630-638. PubMed ID: 16145319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized placebo-controlled study of the effect of transdermal vs. oral estradiol with or without gestodene on homocysteine levels.
    Smolders RG; van der Mooren MJ; Teerlink T; Merkus JM; Kroeks MV; Franke HR; Stehouwer CD; Kenemans P
    Fertil Steril; 2003 Feb; 79(2):261-7. PubMed ID: 12568832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three-year follow-up of the use of transdermal 17beta-estradiol matrix patches for the prevention of bone loss in early postmenopausal women.
    Delmas PD; Pornel B; Felsenberg D; Stakkestad JA; Radowicki S; Garnero P; Hardy P; Dain MP; Petitier B;
    Am J Obstet Gynecol; 2001 Jan; 184(2):32-40. PubMed ID: 11174476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of short-term hormone replacement on serum leptin levels in postmenopausal women.
    Lavoie HB; Taylor AE; Sharpless JL; Anderson EJ; Strauss CC; Hall JE
    Clin Endocrinol (Oxf); 1999 Oct; 51(4):415-22. PubMed ID: 10583307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects of oral and transdermal estradiol treatment on circulating estradiol fatty acid ester concentrations in postmenopausal women.
    Vihma V; Vehkavaara S; Yki-Järvinen H; Hohtari H; Tikkanen MJ
    J Clin Endocrinol Metab; 2003 Feb; 88(2):588-93. PubMed ID: 12574185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral, more than transdermal, estrogen therapy improves lipids and lipoprotein(a) in postmenopausal women: a randomized, placebo-controlled study.
    Hemelaar M; van der Mooren MJ; Mijatovic V; Bouman AA; Schijf CP; Kroeks MV; Franke HR; Kenemans P
    Menopause; 2003; 10(6):550-8. PubMed ID: 14627865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of melatonin administration on glucose tolerance and insulin sensitivity of postmenopausal women.
    Cagnacci A; Arangino S; Renzi A; Paoletti AM; Melis GB; Cagnacci P; Volpe A
    Clin Endocrinol (Oxf); 2001 Mar; 54(3):339-46. PubMed ID: 11298086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-term effects of low-dose estradiol on endothelial function and blood viscosity in nondiabetic postmenopausal overweight women: a double-blind, placebo-controlled study.
    Panazzolo DG; da Silva LH; Maranhão PA; Souza MG; Nogueira Neto JF; Leão LM; Bouskela E; Kraemer-Aguiar LG
    Menopause; 2016 Oct; 23(10):1114-21. PubMed ID: 27404031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia.
    Doehner W; Pflaum CD; Rauchhaus M; Godsland IF; Egerer K; Cicoira M; Florea VG; Sharma R; Bolger AP; Coats AJ; Anker SD; Strasburger CJ
    Eur J Endocrinol; 2001 Dec; 145(6):727-35. PubMed ID: 11720897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of a continuous once-a-week 17beta-estradiol/levonorgestrel transdermal system and its effects on vasomotor symptoms and endometrial safety in postmenopausal women: the results of two multicenter, double-blind, randomized, controlled trials.
    Shulman LP; Yankov V; Uhl K
    Menopause; 2002; 9(3):195-207. PubMed ID: 11973443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of ultralow-dose transdermal estradiol on postmenopausal symptoms in women aged 60 to 80 years.
    Diem S; Grady D; Quan J; Vittinghoff E; Wallace R; Hanes V; Ensrud K
    Menopause; 2006; 13(1):130-8. PubMed ID: 16607109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of the effects of oral and transdermal estrogen replacement on insulin sensitivity in postmenopausal women.
    O'Sullivan AJ; Ho KK
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1783-8. PubMed ID: 7775623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Timing of Estradiol Treatment After Menopause May Determine Benefit or Harm to Insulin Action.
    Pereira RI; Casey BA; Swibas TA; Erickson CB; Wolfe P; Van Pelt RE
    J Clin Endocrinol Metab; 2015 Dec; 100(12):4456-62. PubMed ID: 26425886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of oral and transdermal 17 beta-estradiol combined with progesterone on homocysteine metabolism in postmenopausal women: a randomised placebo-controlled trial.
    Lacut K; Oger E; Abalain JH; Moineau MP; Mottier D;
    Atherosclerosis; 2004 May; 174(1):173-80. PubMed ID: 15135267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Body composition, visceral fat distribution and fat oxidation in postmenopausal women using oral or transdermal oestrogen.
    dos Reis CM; de Melo NR; Meirelles ES; Vezozzo DP; Halpern A
    Maturitas; 2003 Sep; 46(1):59-68. PubMed ID: 12963170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of estradiol and a combined estradiol/progestagen preparation on insulin sensitivity in healthy postmenopausal women.
    Duncan AC; Lyall H; Roberts RN; Petrie JR; Perera MJ; Monaghan S; Hart DM; Connell JM; Lumsden MA
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2402-7. PubMed ID: 10404811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of standard and low dose 17beta-estradiol plus norethisterone acetate on body composition and leptin in postmenopausal women at risk of body mass index and waist girth related cardiovascular and metabolic disease.
    Odabasi AR; Yuksel H; Karul A; Kozaci D; Sezer SD; Onur E
    Saudi Med J; 2007 Jun; 28(6):855-61. PubMed ID: 17530099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.